USPH US PHYSICAL THERAPY INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about US PHYSICAL THERAPY INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 6 reports on USPH from 6 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 1 lowered it.
No firm's latest available rating differs from its previous one.
Latest observed target change: Jefferies raised its target from $96.00 (set 12 Mar 2026) to $101.00 on 27 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barrington Research | Michael Petusky | Buy | 10 Aug 2026 | 98.00 USD |
| Citigroup | Unnamed analyst | Buy | 19 Aug 2026 | — |
| Citizens JMP | Constantine Davides | Buy | 24 Jun 2026 | 98.00 USD |
| Jefferies | Jack Slevin | Buy | 27 Oct 2026 | 101.00 USD |
| JPMorgan | Benjamin Rossi | Buy | 11 Sep 2026 | 95.00 USD |
| Weiss Ratings | Unnamed analyst | — | 26 Aug 2026 | — |
| William Blair | Jared Haase | Hold | 14 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 27 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.